PicnicHealth Raises a $60m Series C to Expand Patient-centered Real-world Data
PicnicHealth, a patient-centered health technology company, today announced the closing of a $60 million Series C financing led by new investor B Capital Group. Existing investors Felicis Ventures and Amplify Partners also joined the round, bringing the total PicnicHealth has raised to more than $100 million. The company also announced plans to build 30 new patient-centered real-world data cohorts, and the addition of Adam Seabrook, Partner at B Capital Group, to the PicnicHealth board of directors.
PicnicHealth takes a patient-centered approach to building deep real-world datasets for life sciences researchers. This compl...
Source: EMR and HIPAA - July 1, 2022 Category: Information Technology Authors: Healthcare IT News Tags: Analytics/Big Data Health IT Company Healthcare IT Adam Seabrook Amplify Partner B Capital Group Felicis Ventures Health IT Funding Health IT Fundings Health IT Investment Noga Leviner PicnicHealth Real-World Data Robert Mittendo Source Type: blogs
What we need to know about environmental toxins [PODCAST]
“Even low dose mercury toxicity can be harmful to human health in a variety of ways: enhanced free radical stress, reduced glutathione levels, increase in apolipoprotein E g4 genotype expression, promotion of neurofibrillary tangles and altered immune sensitivity. It has been implicated in contributing to autism, Alzheimer ’s disease, Parkinsonism, and even lupus erythematosus, an autoimmuneRead more …What we need to know about environmental toxins [PODCAST] originally appeared inKevinMD.com. (Source: Kevin, M.D. - Medical Weblog)
Source: Kevin, M.D. - Medical Weblog - May 7, 2022 Category: General Medicine Authors: < span itemprop="author" > < a href="https://www.kevinmd.com/post-author/the-podcast-by-kevinmd" rel="tag" data-wpel-link="internal" > The Podcast by KevinMD < /a > < /span > Tags: Podcast Pulmonology Source Type: blogs
Fight Aging! Newsletter, May 2nd 2022
In this study, we tested the therapeutic potential of VHHASC and a newly generated VHH against murine ASC (VHHmASC) to target ASC specks in vitro and in vivo. We show that pre-incubation of extracellular ASC specks with VHHASC abrogated their inflammatory functions in vitro. Recombinant VHHASC rapidly disassembled pre-formed ASC specks and thus inhibited their ability to seed the nucleation of soluble ASC. Notably, VHHASC required prior cytosolic access to prevent inflammasome activation within cells, but it was effective against extracellular ASC specks released following caspase-1-dependent loss of membrane integrity, an...
Source: Fight Aging! - May 1, 2022 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
Towards Control of Inflammation as an Important Goal in the Treatment of Aging
Today I'll point out a review article that laments the present state of progress towards the control of inflammation in the human body. While acknowledging that great strides have been made in ways to interfere in inflammatory signaling, benefiting many patients, present tools are crude in comparison to the technologies that will most likely be needed in order to truly control unresolved, chronic inflammation and eliminate its contribution to age-related disease. True control of inflammation would imply the ability to (a) trigger resolution mechanisms with specificity, avoiding impairment of the operation of inflammation w...
Source: Fight Aging! - April 25, 2022 Category: Research Authors: Reason Tags: Medicine, Biotech, Research Source Type: blogs
Merck, GlaxoSmithKline, AbbVie, Sanofi & Bristol Myers Squibb: Big Pharma ’s Extending Digital Health Reaches
A few weeks ago, we kickstarted a new series of articles contemplating the moves of pharmaceutical heavyweights in the digital health arena. The first batch of companies, Johnson & Johnson, Pfizer, Bayer and Novartis, seem to have some interest in remote healthcare solutions and DTx.
In this second article, we will explore which trends pharma giants Merck, GlaxoSmithKline, AbbVie, Sanofi and Bristol Myers Squibb are eyeing.
Merck: big tech-friendly
A big pharma company itself, Germany’s Merck hasn’t shied from teaming up with big tech companies in recent years as it aims to make a lasting footpri...
Source: The Medical Futurist - October 26, 2021 Category: Information Technology Authors: Pranavsingh Dhunnoo Tags: Artificial Intelligence in Medicine Biotechnology Future of Medicine Future of Pharma Health Sensors & Trackers Personalized Medicine Portable Medical Diagnostics Security & Privacy pharmaceutics 23andme philips big pharma Merck Source Type: blogs
How To Slow Down Our Perception of Time
Time has been a great mystery for many philosophers, mathematicians, physicists, and other great thinkers. We often ask ourselves, “Where has the time gone?” As we watch our parents age and our younger relatives grow up, time can be both painful and redeeming. Time is a key component of our daily lives, a guiding force for our behavior. Adults seem to obsess over time that has passed swiftly and recall the days of long summers as a child. There is an ever-present nostalgia for being young again – a period when time seemed to move slowly, languorously. Research suggests that older people underestimate how much time ha...
Source: PickTheBrain | Motivation and Self Improvement - August 4, 2021 Category: Consumer Health News Authors: David Kirichenko Tags: featured happiness productivity tips psychology self-improvement perception of time Source Type: blogs
Does lupus or arthritis affect your prognosis if you get COVID-19?
Soon after the coronavirus pandemic began, we learned that older adults and people with certain chronic conditions, such as high blood pressure or diabetes, are at increased risk for severe COVID-19. One condition on that list is an immunocompromised state (a weakened immune system). This can be due to a number of conditions, including having had an organ transplant, having HIV, or taking medications that suppress the immune system.
If you have an autoimmune condition such as rheumatoid arthritis or lupus (also called systemic lupus erythematosus), you may wonder how this affects your risk. It’s thought that these condit...
Source: Harvard Health Blog - November 9, 2020 Category: Consumer Health News Authors: Robert H. Shmerling, MD Tags: Autoimmune diseases Bones and joints Coronavirus and COVID-19 Source Type: blogs
Autoimmune lung disease: Early recognition and treatment helps
A man who was diagnosed with rheumatoid arthritis (RA) five years ago sees his rheumatologist for a follow-up visit. Fortunately, his arthritis is well controlled through medication. He can walk and do all his daily activities without pain. But over the past six months, he’s been feeling short of breath when climbing stairs. He has an annoying dry cough, too. COVID-19? That’s ruled out quickly. But a CT scan of his chest reveals early fibrosis (scarring) of the lungs, most likely related to rheumatoid arthritis. “I can finally walk normally, and now I can’t breathe when I walk!” says the frustrated patient, whose...
Source: Harvard Health Blog - June 24, 2020 Category: Consumer Health News Authors: Paul F. Dellaripa, MD Tags: Arthritis Autoimmune diseases Health Inflammation Lung disease Source Type: blogs
Podcast: Should I Date Someone With Bipolar Disorder?
Can a relationship work when one person has severe mental illness? In today’s Not Crazy podcast, Gabe and Lisa discuss dating with bipolar disorder. They share their own story of dating, marrying and divorcing under the umbrella of Gabe’s bipolar diagnosis, and discuss the ups and downs from both perspectives.
What are some positive signs that the relationship can last? And what are the clues that you might need to call it quits? Tune in for a heartfelt discussion on living and dating with severe mental illness.
(Transcript Available Below)
Please Subscribe to Our Show:
And We Love Written Reviews!
About ...
Source: World of Psychology - June 16, 2020 Category: Psychiatry & Psychology Authors: Not Crazy Podcast Tags: Bipolar Disorders General Marriage and Divorce Not Crazy Podcast Relationships Source Type: blogs
Adverse effects of hydroxychloroquine
In case you were ever stupid enough to follow Trump’s lead you would have already injected ultraviolets in your eyeballs by now to save you from Covid and maybe bathed in Domestos or sulfuric acid or both! Anyway, his latest bullshine claim is that he’s been taking the antimalarial drug hydroxychloroquine to keep Covid at bay.
Well, for starters there is no evidence that this drug acts as a prophylactic against infection with SARS CoV-2 or indeed any pathogen other than the causative agent of otherwise drug-resistant malaria. It’s primary use is in treating lupus. There was some testing done weeks ago to...
Source: David Bradley Sciencebase - Songs, Snaps, Science - May 19, 2020 Category: Science Authors: David Bradley Tags: Health and Medicine Source Type: blogs
Podcast: Deconstructing Mental Health Month
It’s Mental Health Awareness Month! But what does that mean, exactly? Who are we raising awareness for? Is “mental health” the same as “mental illness?” In this Not Crazy Podcast, Gabe and Lisa ponder the meaning of this decades-old campaign and discuss the pros and cons of the movement.
What do you think? Is Mental Health Awareness Month a necessary outreach that sheds light on mental health, or is it a flimsy substitute for actual help? Tune in for an in-depth discussion that entails several different perspectives.
(Transcript Available Below)
Subscribe to Our Show!
And Please Remember to Review Us!
...
Source: World of Psychology - May 19, 2020 Category: Psychiatry & Psychology Authors: Not Crazy Podcast Tags: General Mental Health and Wellness Not Crazy Podcast Policy and Advocacy Source Type: blogs
Keeping Kids Healthy in the Age of Coronavirus: Dr. Greene on The People s Pharmacy
Transcript
[00:00:00] Joe Graedon: I’m Joe Graedon.
[00:00:01] Terry Graedon: And I’m Terry Graedon. Welcome to this podcast of the People’s Pharmacy.
[00:00:06] Joe Graedon: You can find previous podcasts and more information on a range of health topics at PeoplesPharmacy.com.
[00:00:14] How’s your family holding up during the coronavirus pandemic? Isolation can be especially challenging for children.
[00:00:22] This is the People’s Pharmacy with Terry and Joe Graedon.
[00:00:33] Terry Graedon: Children appear less susceptible than older adults to serious complications of COVID-19...
Source: Conversations with Dr Greene - April 21, 2020 Category: Child Development Authors: Alan Greene MD Tags: Dr. Greene's Blog COVID COVID-19 Viral Infection Source Type: blogs
Keeping Kids Healthy in the Age of Coronavirus: Dr. Greene on The People ’ s Pharmacy
Transcript
[00:00:00] Joe Graedon: I’m Joe Graedon.
[00:00:01] Terry Graedon: And I’m Terry Graedon. Welcome to this podcast of the People’s Pharmacy.
[00:00:06] Joe Graedon: You can find previous podcasts and more information on a range of health topics at PeoplesPharmacy.com.
[00:00:14] How’s your family holding up during the coronavirus pandemic? Isolation can be especially challenging for children.
[00:00:22] This is the People’s Pharmacy with Terry and Joe Graedon.
[00:00:33] Terry Graedon: Children appear less susceptible than older adults to serious complications of COVID-19...
Source: Conversations with Dr Greene - April 21, 2020 Category: Child Development Authors: Alan Greene MD Tags: Dr. Greene's Blog COVID COVID-19 Viral Infection Source Type: blogs
My Experiences with Hydroxychloroquine Urge Caution and Ethical Research into COVID19 Therapies
by Keisha Ray, Ph.D.
I take the drug hydroxychloroquine, brand name Plaquenil, for an autoimmune disease. Hydroxychloroquine was once used to treat malaria and is now commonly used to treat a range of inflammatory disorders like lupus and rheumatoid arthritis. If this drug sounds familiar it is likely because it has frequently been in the news as a potential therapy for COVID19. During multiple press conferences the president has touted this drug as a potential cure for COVID19. Medical professionals like Dr.… (Source: blog.bioethics.net)
Source: blog.bioethics.net - April 20, 2020 Category: Medical Ethics Authors: Keisha Ray Tags: Ethics Featured Posts Health Care Health Policy & Insurance Human Subjects Research & IRBs Informed Consent Pharmaceuticals Politics Public Health #covid19 #diaryofaplagueyear COVID-19 Source Type: blogs
COVID-19: Hidden Coinfections and Chain Reactions Parasitic Infectious Relationships within Us
By SIMON YU, MD, LT COL, USA (Ret)
Dr. Tom Frieden, former director of the Centers for Disease Control and Prevention (CDC), opened up a new front in the Coronavirus War by saying we don’t just need to treat the acute disease, we need to treat the underlying conditions that make people more susceptible to serious disease progression. He focused on heart disease, and managing mitigating risk factors such as CVD, diabetes, hypertension and smoking in order to increase people’s odds for recovery. The initial focus has been pneumonia and acute respiratory distress syndrome (ARDS), with risk factors including asthma, chr...
Source: The Health Care Blog - April 15, 2020 Category: Consumer Health News Authors: Christina Liu Tags: COVID-19 CDC chronic disease holistic care Pandemic SDoH Source Type: blogs
